Skip to content
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Medical Genetics · GLS Gain-of-Function Disorder and MSMO1 Deficiency

Understanding Your Child's Rare Symptom Cluster

At a Glance

Infantile cataracts with skin changes, excess glutamate, and developmental delay may reflect a rare metabolic disorder, but symptoms alone do not identify the cause. A metabolic genetics team can use genetic testing, specialized sterol testing, and review of glutamate results.

When a child is born with a rare combination of symptoms like infantile cataracts (clouding of the eye’s lens before age one) [1], skin issues, and developmental delays, it can feel like you are navigating an uncharted map. It is normal to feel overwhelmed when your local doctors—who may see thousands of children—have never encountered this specific “cluster” before.

These symptoms often point to a rare metabolic disorder, a condition where the body’s internal chemistry is slightly “off” because a specific protein or enzyme is not working correctly. While this symptom cluster has many causes, one possibility your team may consider is that the combination of cataracts and high glutamate (a chemical messenger in the brain) or abnormal sterols (building blocks for cholesterol) suggests two primary pathways: GLS gain-of-function or MSMO1 deficiency. You should never interpret a single glutamate result without a metabolic specialist, as levels fluctuate with specimen handling, illness, or seizures.

The Role of Glutamate and the GLS Variant

If your child has been found to have excessive levels of glutamate, doctors may look at a gene called GLS. This gene provides instructions for making glutaminase, an enzyme that creates glutamate [2].

In a “gain-of-function” variant, this enzyme becomes overactive. It stops listening to the body’s “off” signals and produces far too much glutamate while using up too much glutamine (another important chemical) [1][2].

  • The Brain and Development: High glutamate in the brain is reported in some individuals to be linked to severe developmental delay and intellectual disability [1].
  • Seizure Risk: Unlike some other metabolic conditions, some children reported with GLS gain-of-function variants develop epilepsy (recurring seizures) [1][2].
  • Eye Health: Research in animal models hypothesizes that excessive glutamate or the oxidative stress it causes can damage the lens of the eye, leading to infantile cataracts [1].

The Link Between Skin, Sterols, and MSMO1

If your child’s symptoms include specific skin changes—such as psoriasiform dermatitis (red, scaly patches) or ichthyosis (thick, scaly skin)—doctors may investigate MSMO1 deficiency (also known as SC4MOL deficiency) [3][4].

This is a disorder of distal cholesterol synthesis, meaning the body struggles to complete the final steps of making cholesterol [3]. This process is vital for building healthy skin and eye lenses.

  • Skin and Growth: Common findings include severe scalp dandruff, skin scaling, and growth delay (being smaller or shorter than expected) [4][5].
  • Immune System: Some children with this condition have immune dysfunction, making them more susceptible to infections [3].
  • Variable Outlook: The course of MSMO1 deficiency varies. Some children have severe developmental delays, while others have reached adulthood with more manageable symptoms, such as mild learning difficulties and skin issues [3][4].

Managing Ultra-Rare Symptoms

Because these conditions are “ultra-rare,” there is no single “standard” treatment that works for every child. Instead, care is focused on managing each symptom to improve quality of life.

Vision and Eyes

Early intervention by a pediatric ophthalmologist is critical. If the cataracts significantly block vision, surgery may be considered to prevent amblyopia (lazy eye) and ensure the brain learns to process visual information [6].

Skin and Metabolism

For MSMO1 deficiency, some specialists have attempted off-label, experimental treatments using a combination of oral cholesterol supplements and statins (medications usually used for high cholesterol, but here used to balance specific sterol levels) based on small case reports [4][5]. In some cases, compounded topical cholesterol creams applied directly to the skin have been tried [5]. There is no standardized dose, and these must never be obtained or applied without the strict oversight of a treating metabolic team. Improvement in skin findings does not prove a benefit for cataracts or neurological development.

Neurological Support

Because both conditions can involve developmental delays, early therapy (physical, occupational, and speech) is a cornerstone of care [4][3]. If your child shows signs of seizures—such as staring spells or sudden jerks—an EEG (a test that records brain activity) is often the next step based on the neurologist’s judgment [1].

Why Your Care Team Matters

In the world of rare disease, you are often the “expert” on your child, while your doctors provide the medical framework. Because local pediatricians may not have the resources to interpret complex metabolic labs, your child’s care should ideally be coordinated by a metabolic geneticist at a major academic or research hospital. These specialists have access to the specific sterol profiling and advanced genetic testing needed to distinguish between these rare conditions [3][4].

Common questions in this guide

What could cause infantile cataracts, skin changes, high glutamate, and developmental delay?
Many conditions can produce this combination, so it is not diagnostic by itself. Two rare metabolic possibilities are a gain-of-function change in GLS and MSMO1, also called SC4MOL, deficiency. A metabolic geneticist can combine the examination, laboratory studies, and genetic results to narrow the cause.
Can one high glutamate result confirm a GLS disorder?
No. A single high glutamate result does not confirm a GLS gain-of-function disorder because levels can change with specimen handling, illness, or seizures. Doctors consider whether the result came from blood, urine, or a brain scan and interpret it alongside genetic and metabolic testing.
What is MSMO1 or SC4MOL deficiency?
MSMO1 or SC4MOL deficiency is a rare disorder in which the body cannot complete the final steps of making cholesterol. It can cause scaly or inflamed skin, growth delay, immune problems, and variable developmental effects.
What tests may help distinguish GLS and MSMO1-related conditions?
Genetic testing can assess GLS and MSMO1 variants. A specialized sterol profile can look for C4-monomethyl and C4-dimethyl sterols, while glutamate results must be interpreted according to the specimen type and clinical context. If seizure signs are present, a neurologist may recommend an EEG to record brain activity.
What treatments are available for a child with this symptom cluster?
Treatment is individualized because no single standard treatment covers all possible causes. A pediatric ophthalmologist may recommend cataract surgery if vision is blocked, and physical, occupational, or speech therapy can support development. For MSMO1 deficiency, oral cholesterol, statins, or compounded topical cholesterol have been tried experimentally and should only be used under strict metabolic-team supervision.
Which specialists should care for a child with these symptoms?
A metabolic geneticist at a major academic or research center can coordinate the evaluation. Depending on the findings, care may also include pediatric ophthalmology, neurology, dermatology, and developmental therapy providers.
What signs might mean my child needs seizure evaluation?
Staring spells, sudden jerking movements, or periods of unresponsiveness can be signs of seizures, although they can have other causes. A neurologist may recommend an EEG to record brain activity and decide whether more evaluation or treatment is needed.

Get notified when new evidence is published on infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    GLS hyperactivity causes glutamate excess, infantile cataract and profound developmental delay.

    Rumping L, Tessadori F, Pouwels PJW, et al.

    Human molecular genetics 2019; (28(1)):96-104 doi:10.1093/hmg/ddy330.

    PMID: 30239721
  2. 2

    Structure and enzymology of glutaminase S482C and H461L variants associated with excess brain glutamate and neurological disease.

    Crane CS, McIssac TK, Milano SK, et al.

    The Journal of biological chemistry 2026; (302(6)):113091 doi:10.1016/j.jbc.2026.113091.

    PMID: 42055345
  3. 3

    A rare case of sterol-C4-methyl oxidase deficiency in a young Italian male: Biochemical and molecular characterization.

    Frisso G, Gelzo M, Procopio E, et al.

    Molecular genetics and metabolism 2017; (121(4)):329-335 doi:10.1016/j.ymgme.2017.06.013.

    PMID: 28673550
  4. 4

    MSMO1 deficiency: a potentially partially treatable, ultrarare neurodevelopmental disorder with psoriasiform dermatitis, alopecia and polydactyly.

    Tkemaladze T, Bratland E, Bregvadze K, et al.

    Clinical dysmorphology 2023; (32(3)):97-105 doi:10.1097/MCD.0000000000000461.

    PMID: 37195326
  5. 5

    New Homozygous Missense MSMO1 Mutation in Two Siblings with SC4MOL Deficiency Presenting with Psoriasiform Dermatitis.

    Kalay Yildizhan I, Gökpınar İli E, Onoufriadis A, et al.

    Cytogenetic and genome research 2020; (160(9)):523-530 doi:10.1159/000511126.

    PMID: 33161406
  6. 6

    Infantile Cataracts Associated with a Homozygous Missense MSMO1 Variant-Case Report and Literature Review.

    Hassas N, Drackley A, Ivanisevic J, et al.

    Reports (MDPI) 2026; (9(1)) doi:10.3390/reports9010045.

    PMID: 41718295

This page is for education about possible metabolic causes of a child’s symptom cluster and does not diagnose or replace medical advice. A metabolic geneticist and the child’s treating specialists should interpret test results and supervise any treatment.